Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)128-130
Number of pages3
JournalEuropean Journal of Cancer
Volume96
DOIs
Publication statusPublished - Jun 2018

Cite this